Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 20, 2023 at 04:44 pm EST
Share
Pressure BioSciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 0.413009 million compared to USD 0.144032 million a year ago. Net loss was USD 5.63 million compared to USD 4.46 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.44 a year ago.
For the nine months, revenue was USD 1.67 million compared to USD 1.12 million a year ago. Net loss was USD 19.41 million compared to USD 11.62 million a year ago. Basic loss per share from continuing operations was USD 1.21 compared to USD 1.24 a year ago.
Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.
PRESSURE BIOSCIENCES, INC. 
